Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CRBU
#3632
Caribou Biosciences, Inc. Common Stock
2.2
0
USD
+3.77%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.77%
Monthly Change
+16.40%
6 month change
-22.26%
Year Change
+185.71%
Previous Close
2.1
2
Open
2.2
0
Bid
Ask
Low
2.2
0
High
2.2
0
Volume
22
Markets
US Stock Market
Healthcare
CRBU
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
93 M
93 M
93.12 M
93.47 M
96.64 M
—
Valuation ratios
Enterprise value
158.09 M
55.51 M
92.13 M
206.64 M
141.29 M
495.57 M
Price to earnings ratio
-0.96
-0.56
-0.71
-1.37
-1
-3.64
Price to sales ratio
14.37
8.37
12.67
23.16
13.31
57.51
Price to cash flow ratio
-1.04
-0.6
-0.87
-1.71
-1.34
-4.52
Price to book ratio
0.57
0.08
0.13
0.28
1.22
1.69
Enterprise value to EBITDA ratio
-0.97
-0.35
-0.57
-1.34
-0.98
-3.23
Profitability ratios
Return on assets %
-0.11
-0.15
-0.24
-0.14
-0.15
-0.68
Return on equity %
-0.14
-0.18
-0.33
-0.19
-0.22
-0.92
Return on invested capital %
-148.48
-215.16
-402.45
-301.94
-287.31
-1 206.88
Gross margin %
100
100
100
100
100
400
Operating margin %
-1 871.69
-1 823.76
-1 783.95
-1 337.58
-721.97
-5 667.26
EBITDA margin %
-1 814.68
-1 774.25
-1 740.19
-1 308.87
-704.67
-5 527.98
Net margin %
-1 708.71
-1 699.58
-2 028.42
-1 253.32
-672.11
-5 653.43
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.16
7.63
6.66
5.54
5.71
25.55
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.01
0.01
0.01
0.01
0.02
0.05
Solvency ratios
Debt to assets ratio
0.08
—
—
—
—
—
Debt to equity ratio
0.1
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.39
-0.4
-0.3
-0.27
-0.22
-1.19
EBIT per share
-0.43
-0.46
-0.51
-0.32
-0.3
-1.59
EBITDA per share
-0.42
-0.45
-0.5
-0.31
-0.3
-1.56
Total debt per share
0.29
—
—
—
—
—
Cash per share
2.76
2.29
1.98
1.71
1.53
7.51
Net current asset value per share
2.43
2.34
2.07
1.67
1.56
7.64
Tangible book value per share
2.8
2.34
1.79
1.52
1.31
6.96
Working capital per share
2.09
2.04
1.76
1.37
1.28
6.45
Book value per share
2.8
2.34
1.79
1.52
1.31
6.96
News
Three Best Genomics Stocks for Your Portfolio in 2026
Sarepta Therapeutics (SRPT) Soars 35.0%: Is Further Upside Left in the Stock?
Caribou Biosciences: Antlers Up For The Allogenic CAR-T Bet Trading At Cash Value
Is CareCloud (CCLD) Outperforming Other Medical Stocks This Year?
Truist reiterates Buy on Caribou Biosciences stock, $7 target
Caribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Tops Revenue Estimates
Caribou Biosciences earnings beat by $0.04, revenue topped estimates
EyePoint (EYPT) Reports Q4 Loss, Tops Revenue Estimates
Urogen Pharma (URGN) Reports Q4 Loss, Beats Revenue Estimates
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss, Tops Revenue Estimates
Caribou Biosciences CLO sold $13,598 in CRBU stock
Caribou Biosciences CTO Kelly sells $6.1k in shares